Supplementary Table 2 from Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

Open Access

Publisher Website

30 March 2023

other
Published by American Association for Cancer Research (AACR)

https://doi.org/10.1158/0008-5472.22371174

Abstract

Supplementary Table 2 from Therapeutic Efficacy of ABT-737, a Selective Inhibitor of BCL-2, in Small Cell Lung Cancer

Keywords